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MECHANISMS OF ACTION OF ESE1, A NOVEL TRANSCRIPTIONAL
REGULATOR OF CARTILAGE REMODELING, IN MMP-13 REGULATION
E. Olivotto1,2, M. Otero1, D.A. Plumb1, C. Dragomir1, K. Tsuchimochi3,
R.M. Borzì2, A. Facchini2, K.B. Marcu4,2, M.B. Goldring1
1Hosp. for Special Surgery, New York, NY; 2Istituti Ortopedici Rizzoli, Bologna,
Italy; 3Kagoshima Univ., Kagoshima, Japan; 4Stony Brook Univ., Stony Brook,
NY
Purpose: Matrix metalloproteinase (MMP)-13 plays a major role in car-
tilage degradation. MMP-13 expression and activity are up-regulated in
osteoarthritis (OA) cartilage as compared to non-OA cartilage. We previ-
ously reported that ELF3/ESE1 levels are higher in OA cartilage and that
ESE-1 transactivates the MMP13 promoter via a proximal highly conserved
ETS binding site. The aim of this study was to better deﬁne the mech-
anism/s and signalling pathways that modulate the ESE-1-driven MMP13
promoter activation in chondrocytes.
Methods: We investigated the contribution of ESE-1 to MMP-13 expression
by siRNA knock down (KD) transfection experiments in human primary
chondrocytes and real time PCR analysis of MMP-13 expression induced by
IL-1β. The response of the MMP13 promoter to ESE-1 was analyzed in lu-
ciferase reporter assays, after co-transfection of immortalized chondrocytes
with human MMP13 promoter constructs and expression vectors encoding
ESE-1, p38, JNK, ERK-1, MKK-6, MKK-7, MEK-1 and MKP-1. ESE-1 binding
to the MMP13 promoter was analyzed by chromatin immunoprecipitation
(ChIP) assays. IL-1β-induced ESE-1 nuclear translocation was addressed by
Western blotting analysis of cytoplasmic and nuclear fractions of human
immortalized chondrocytes.
Results: Real time PCR analysis revealed a signiﬁcant reduction of IL-
1β-induced MMP-13 mRNA levels associated with ESE-1 KD in human
primary chondrocytes. Luciferase reporter assays showed that MEK1/ERK1
overexpression enhanced ESE1-driven activities of the -1528/+27 and -
267/+27 MMP13 promoter constructs, whereas MKK6/p38 or MKK7/JNK
overexpression did not affect ESE-1 transactivation of MMP-13. Over-
expression of MKP-1 reduced both the ESE-1 activation of MMP13 and
also the MEK1/ERK1 enhancement of ESE-1-driven MMP13 activation.
Accordingly, pre-treatment with the MEK1/2 inhibitor, U0126, decreased
the MMP13 promoter activity induced by ESE-1 overexpression. Finally,
Western blotting analysis revealed that IL-1β stimulation induced ESE-1
nuclear translocation, which correlated with increased ESE-1 binding to the
endogenous MMP13 promoter, as addressed by ChIP assays.
Conclusions: The role of MMP-13 as a central factor for OA progression
has been highlighted by recent studies in Mmp13 knockout mice. We
previously reported that ESE-1 is a key factor in controlling MMP13 tran-
scription. ESE-1 belongs to the ETS family of transcription factors, which
are classic MAPK effectors in different tissues and cell types. Here, we
show that ESE-1 participates in the IL-1β-induced MMP-13 expression
and that IL-1β induces ESE-1 nuclear translocation and binding to the
MMP13 promoter. In addition, we show that the ESE1-driven transacti-
vation of MMP13 is enhanced by MEK1/ERK1. In chondrocytes, ERK1/2
phosphorylation is increased in vitro in response to IL-1β and in vivo in
OA cartilage, and MEK/ERK activation has been reported to participate in
the cytokine-induced MMP-13 expression. Therefore, ESE-1 could be one of
the effectors of the MEK/ERK pathway in controlling MMP-13 expression
in chondrocytes, and the relative contributions of the MEK/ERK/ESE1 axis
in OA with regard to MMP-13 expression and activity will merit further
investigation.
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TEMPORAL EXPRESSION AND TISSUE DISTRIBTUTION OF
INTERLEUKIN-1B IN TWO STRAINS OF GUINEA PIGS WITH VARYING
DEGREES OF SPONTANEOUS OSTEOARTHRITIS
K.S. Santangelo, G.J. Nuovo, E. Pieczarka, S.E. Weisbrode, A.L. Bertone
The Ohio State Univ., Columbus, OH
Purpose: Interleukin-1β (IL-1β) has been cited as a major cytokine involved
in OA-related joint degeneration but deﬁnitive characterization of its role
in vivo remains elusive. The objective of this study was to determine
the temporal expression and tissue distribution of IL-1β in whole knee
joints harvested from OA-prone and resistant guinea pigs via immuno-
histochemistry (IHC). Two main hypotheses were tested: 1) differences in
IL-1β expression would be detected in joint tissue of OA-prone animals
during the course of disease progression; and 2) IL-1β expression patterns
in OA-prone animals would differ from that of OA-resistant animals.
Methods: OA-prone Hartley (N=24) and OA-resistant Strain 13 (N=24)
guinea pigs were collected at 60, 120, 180, 240, 360, and 480 days of age
(N=4 per strain per time point). IHC was performed on paraﬃn-embedded
sections of whole knee joints and the distribution of IL-1β expression in
all tissue was both descriptively described and scored. OA was graded on
toluidine blue stained coronal sections using Mankin criteria with modiﬁ-
cations speciﬁc for the guinea pig. Data was reported as median and range,
and statistical analysis was performed using the Kruskal-Wallis one-way
analysis of variance by ranks followed by Dunn’s post test.
Results: Median OA scores for both strains increased from 60 to 480
days of age, and a statistically higher score (p≤0.01) was found in Hartley
animals by 480 days of age. The tissue distribution and intensity of IL-1β
immunostaining was consistent within the knee joint organs for each group
(strain and age) examined, allowing identiﬁcation of differing expression
patterns in cartilage, synovium, menisci, and subchondral bone both within
and between guinea pig models over time. The most striking ﬁnding was
persistent IL-1β expression in all aforementioned tissues in Hartley guinea
pigs at 120 and 180 days of age, while Strain 13 animals demonstrated a
signiﬁcant (p≤0.05) and marked reduction in positive cells and/or matrix at
these same time points. Further, when present, the distribution of positive
protein detection often varied within tissue type for each guinea pig strain.
For example, descriptive regional differences in weight-bearing cartilage
were discerned between guinea pig strains at 360 and 480 days of age.
Immunostaining in the cartilage of Hartley guinea pigs at these time points
was restricted to midline and medial or lateral regions, while positive
cells and/or matrix of Strain 13 animals were present only in central
regions.
Conclusions: This study provides evidence that IL-1β continues to be
an important biomarker relevant to the development and progression of
OA. Although these ﬁndings do not directly explicate a cause-and-effect
relationship between IL-1β and OA, data is provided as to a window of time
when targeted cytokine reduction and/or blockade may prove effective in
elucidating such a correlation and identifying its mechanistic components.
In this vein, in vitro and in vivo investigations are underway to determine
the effects that reduction of IL-1β via RNA interference may have on other
key mediators implicated in OA. Alternately, should IL-1β, itself, prove to
represent only a secondary response to a more primary insult propagating
OA pathogenesis, groundwork has been laid to hone in on the offending
pathway.
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THE COMBINATION OF IL-4 AND IL-10 PROTECTS AGAINST
BLOOD-INDUCED CARTILAGE DAMAGE
M.E. van Meegeren1,2, S.C. Mastbergen1, N.W. Jansen1,2, G. Roosendaal2,
F.P. Lafeber1
1Rheumatology & Clinical Immunology, Univ. Med. Ctr. Utrecht, Utrecht,
Netherlands; 2Haematology and Van Creveld Clinic, Univ. Med. Ctr. Utrecht,
Utrecht, Netherlands
Purpose: Exposure of cartilage to blood can occur after joint trauma, during
or after major joint surgery, or in hemophilia patients. This ultimately
leads to joint damage, having both the inﬂammatory characteristics of
rheumatoid arthritis and the degenerative characteristics of osteoarthritis.
It was shown that in vitro exposure of cartilage to 50% v/v blood for 4
days, the supposed natural evacuation time of blood from a joint, leads to
98% inhibition of cartilage matrix synthesis. Even after a recovery period
of 12 days (in the absence of blood) cartilage matrix synthesis is still
inhibited by 78%. We have previously demonstrated that interleukin (IL)-10
limits in vitro blood-induced cartilage damage. In addition, IL-4 has been
suggested to have cartilage protective properties. Hence our aim was to
study whether IL-4 can support IL-10 in the prevention of blood-induced
cartilage damage.
Methods: Human full thickness articular cartilage explants were cultured
for 4 days in the presence or absence of 50% v/v homologous blood. IL-4
was added in concentrations of 0, 1, 3, 10, 30, or 100 ng/ml during blood
exposure. A combination of IL-4 and IL-10 was added in a concentration
of 100 ng/ml. After 4 days the medium was refreshed and cartilage was
cultured for an additional 12 days in the absence of additives to determine
long-term effects of short-term blood-exposure and treatment. Cartilage
matrix turnover, in terms of proteoglycan synthesis, -release, and -content,
was determined at day 16.
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Results: Cartilage cultured in the presence of blood showed a decrease
of proteoglycan synthesis rate of 70%, an increase of proteoglycan release
of 100%, and a decrease of proteoglycan content of 15% after 16 days of
culture (all p<0.05). This blood-induced damage of the cartilage matrix
was limited by IL-4 in a clear dose-dependent way. Addition of 100 ng/ml
IL-4 during blood-exposure reduced the proteoglycan synthesis rate with
only 45%, and decreased the proteoglycan release with 30% compared
to control (all p<0.05). Moreover, proteoglycan content was normalized.
The combination of IL-4 and IL-10 was clearly more protective against
damage caused by blood. This was especially evident for the proteoglycan
synthesis which was completely normalized. Furthermore, treatment with
a combination of the two cytokines was signiﬁcantly better than the effect
of IL-4 and IL-10 alone (p<0.05).
Conclusions: Besides IL-10, as shown previously, also IL-4 protects against
blood-induced cartilage damage. The combination of these two cytokines
is clearly the most protective. In addition to the direct effects on cartilage,
both cytokines are synergistic in inhibition of inﬂammation. As such,
this justiﬁes further evaluation of the combination of IL-4 and IL-10 in
prevention and treatment of blood-induced joint damage.
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BRADYKININ, THROUGH B2 RECEPTORS, ACTIVATES THE RELEASE OF THE
CYTOKINE INTERLEUKIN 6, THE CHEMOKINE INTERLEUKIN 8, AND THE
METALLOPROTEINASE 3 IN HUMAN KNEE CHONDROCYTES
S. Meini, P. Cucchi, F. Bellucci, C. Catalani, S. Giuliani, C.A. Maggi
Menarini Ricerche S.p.A., Florence, Italy
Purpose: Bradykinin (BK, H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH) is a
proinﬂammatory and algogenic peptide: it releases inﬂammatory media-
tors and sensitizes sensory afferents through the activation of B2 receptors
expressed on the membrane of several cell types, including synoviocytes
and chondrocytes. Aim of the current investigation was to investigate if BK
and B2 receptor can participate into mechanisms which are involved into
ostearthritis (OA) degenerative events, and to evaluate the possibility to
prevent them through B2 receptor blockade, using the highly selective and
potent B2 receptor antagonist MEN16132 (m.w. 873.16).
Methods: Human chondrocytes (Lonza, CC-2550) were cultured in
F12/DMEM 1:1 added with CGM Singlequots (Lonza, CC-4409) and Gln
2mM and used up to ﬁfth passage. Experiments were performed with
cells at conﬂuence plated onto 24-well plates. Cells were incubated at
the indicated concentration of BK in F12 medium supplemented with
foetal bovine serum (1%), penicillin (50 μg/ml), streptomycin (50 μg/ml),
amphotericin B (0.75 μg/ml), Gln (2 mM), and captopril (1 μM). At the
end of the experiments, surnatants were collected and stored at -80°C
and used for the dosage of interleukin 6 (IL-6), interleukin 8 (IL8), and
metalloproteinase 3 (MMP3). IL-6, IL-8, and MMP3 contents in the super-
natant were assayed by commercially available enzyme immunoassay kits
(Promokine PK-EL-61606, PK-EL-61806, and Biosource KAC1541). Data are
expressed as mean ± s.e.m. or 95% conﬁdence limits in parentheses of 3 to
5 experiments, each in triplicate.
Results: Time-course experiments (2 - 96 h) indicated that BK (1 μM)
induced a release of IL-6, IL-8, and MMP3 which increased over the time,
stably peaked after 24 h of incubation, and remained constant up to 96
h. The maximal production of IL-6, IL-8 and MMP3 induced by BK (24 h
incubation) was 557±39 pg/ml, 1267±169 pg/ml, and 5.52±0.73 ng/ml,
respectively and was resembling that induced by the pleiotropyc cytokine
TNFα (0.1 ng/ml)(817±350 pg/ml, 1778±198 pg/ml, and 1.96±0.2 ng/ml,
respectively). Concentration-response curves to BK (0.1 nM - 1 μM, 24 h)
indicated EC50 values of 10 nM (5.4-18.6) in inducing an augmented release
of IL-6, 9.7 nM (3.7-32.5) for the release of IL-8, and 9.1 nM (1.1-7.6) for
MMP3 secretion. This effect provoked by BK (100 nM, submaximal concen-
tration) were concentration-dependently prevented by the pretreatment
of HCCK (30 min) with the selective B2 receptor antagonist MEN16132,
and IC50 values were 1.7 nM (1.0-2.8) to inhibit IL-6 production, 2.2 nM
(0.7-7.1) for IL-8, and 0.7 nM (0.3-1.4) for inhibition of MMP3 secretion.
Conclusions: These ﬁndings disclose novel actions of BK that imply its pos-
sible involvement in joint degenerative diseases, and indicate B2 receptor
blockade as a potential therapy in OA pathology.
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CARTILAGE THICKENING IN EARLY RADIOGRAPHIC KNEE
OSTEOARTHRITIS - FACT OR ARTIFACT?
S. Cotofana1, W. Wirth1, R.J. Buck2, F. Roemer3, D. Dreher4, M. Nevitt5,
F. Eckstein1
1PMU-Salzburg, Salzburg, Austria; 2StatAnswers Consulting LLC, San Diego, CA;
3Quantitative Imaging Ctr., Dept. of Radiology, Boston, MA; 4Merck Serono,
Geneva, Switzerland; 5UCSF, San Francisco, CA
Purpose: In animal studies of osteoarthritis (OA), increases in cartilage
thickness have been observed at the early phases, due either to cartilage
hypertrophy or edema. Evidence for cartilage thickening in human OA,
however, remains enigmatic. Cross sectional analyses and one longitudinal
study in human with MRI have indicated that medial osteophytes, in the
absence of medial joint space narrowing (JSN), may be associated with
cartilage thickening in the medial femorotibial compartment in human OA,
particularly in the external aspect of the medial femoral condyle (ecMF).
However, comparisons may have been confounded by differences in age,
BMI and other factors.
To eliminate confounding by between-person differences and to enhance
sensitivity, we performed a within-person between-knee analysis of carti-
lage thickness in knees with unilateral osteophytes and without JSN. The
primary endpoint was the between-knee cartilage thickness differences
in ecMF (in subjects with unilateral medial osteophytes), the secondary
endpoint was thickness differences in the external lateral femur (in those
with unilateral lateral osteophytes), and the exploratory endpoints were
thickness differences in all other femorotibial subregions.
Methods: 83 OA Initiative participants were selected from 4800 cases
(public use data sets 0.E.1 [imaging] and 0.2.2 [clinical]), who displayed
deﬁnite osteophytes and no JSN in one knee and no signs of radiographic
OA in the other knee, according to the site readings. The radiographs
were reviewed by a central reader (F.R.) and 61 participants were in-
cluded. Cartilage thickness was measured in four femorotibial cartilage
plates (medial/lateral, femur/tibia) and in 16 femorotibial subregions, using
sagittal DESSwe MR images and dedicated software (Chondrometrics).
Within-person between-knee differences were calculated with a paired
t-test and general linear models. No adjustment for multiple comparisons
was performed.
Results: Of the 61 participants (age 60.8±9.6 yrs; 29m/32f; BMI 27.8±4.7)
48% displayed medial, 36% lateral, and 16% bicompartimental (mostly tibial)
osteophytes. Knees with osteophytes had thicker cartilage than contralat-
eral knees in the external medial (ecMF:+5.5%,p=0.02) and external lateral
femur (ecLF:+4.1%,p=0.01), but in no other subregions. Knees with only
medial osteophytes displayed greater thickening in ecMF (+7.8%) than ecLF
(-0.1%), those with only lateral osteophytes greater thickening in ecLF
(+5.0%) than in ecMF (+1.7%), and those with bicompartimental osteophytes
similar thickening in both subregions (+17%/+15%, respectively). There was
no signiﬁcant effect of age, sex, or BMI on between-knee differences.
Conclusions: Knees with early radiographic OA (deﬁnite osteophytes, no
JSN) displayed thicker cartilage than the contralateral knees without radio-
graphic OA. The differences were speciﬁc to external medial femoral and
external lateral femoral subregions and appeared to be locally mediated by
(tibial) osteophytes in the same compartment.
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SUPEROXIDE DISMUTASE 2 DOWNREGULATION AND MITOCHONDRIA
RESPIRATION IN OSTEOARTHRITIS
C. Gabrielides1 , J.L. Scott1, R.W. Taylor2, D.A. Young1
1Musculoskeletal Res. Group, Inst. of Cellular Med., Newcastle Univ., Newcastle
Upon Tyne, United Kingdom; 2Inst. for Ageing and Hlth., Newcastle Univ.,
Newcastle Upon Tyne, United Kingdom
Purpose: Oxidative phosphorylation takes place at the mitochondrial res-
piratory chain and is the major source for the production of ATP. A
by-product of this respiration are reactive oxygen species (ROS). ROS are
involved in signalling processes but when at high levels contribute to
oxidative damage. The major ROS include superoxide (O2•–) and hydrogen
peroxide (H2O2). The mRNA and protein levels of the major inhibitor of
superoxides in the mitochondria, superoxide dismutase 2 (SOD2), have
been shown to be downregulated in osteoarthritic compared to healthy
joint cartilage.
This study characterises the effects of reduced levels of SOD2 on chondro-
